High bax expression modulates response to treatment and survival in AML.

High bax expression modulates response to treatment and survival in AML.

Detalhes bibliográficos
Main Authors:	Truran, L, Kell, J, Nicholson, D, Harrison, G, Hoy, T, Burnett, A
Formato:	Journal article
Publicado em:	1999

Registos relacionados

Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis
Por: Nadege Gitego, et al.
Publicado em: (2023-12-01)

Bim, Bak, and Bax regulate osteoblast survival.
Por: Liang, M, et al.
Publicado em: (2008)

THE CHALLENGE OF AML IN OLDER PATIENTS
Por: Alan K Burnett
Publicado em: (2013-06-01)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
Por: Grimwade, D, et al.
Publicado em: (1999)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
Por: Grimwade, D, et al.
Publicado em: (1996)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
Por: Peniket, A, et al.
Publicado em: (1999)

THE EFFECT OF UREA SUPLEMENTATION IN MATURATION MEDIA OF BOVINE OOCYTE IN VITRO TOWARDS EXPRESSION OF BAX, BCL-2 AND BAX/BCL-2 RATIO
Por: Dhesy Kartikasari, et al.
Publicado em: (2020-04-01)

Leptin and curcumin affect renal ischemia-reperfusion injury via modulation of P65 and Bax genes expression
Por: M. M. Ragy, et al.
Publicado em: (2021-02-01)

Regulation of HOX gene expression in AML
Por: Irum Khan, et al.
Publicado em: (2024-03-01)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
Por: Grimwade, D, et al.
Publicado em: (2001)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
Por: Grimwade, D, et al.
Publicado em: (1998)

8-Hydroxydaidzein Induces Apoptosis and Inhibits AML-Associated Gene Expression in U-937 Cells: Potential Phytochemical for AML Treatment
Por: Pei-Shan Wu, et al.
Publicado em: (2023-10-01)

Coenzyme Q10 Protects Hippocampal Neurons against Ischemia/ Reperfusion Injury via Modulation of BAX/Bcl-2 Expression
Por: Mohammad Zamani, et al.
Publicado em: (2012-09-01)

Coenzyme Q10 Protects Hippocampal Neurons Against Ischemia/Reperfusion Injury via Modulation of BAX/Bcl-2 Expression
Por: M Zamani, et al.
Publicado em: (2012-12-01)

Association between reproducible flow cytometric methodology for measuring multidrug resistance and remission rates in AML
Por: Pallis, M, et al.
Publicado em: (1998)

Investigation into the Effect of Aspartame on the Expression of p53 and BAX in Mouse Stomach Tissue
Por: Angelique Cheryl, et al.
Publicado em: (2024-12-01)

The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma
Por: Nenad Kunac, et al.
Publicado em: (2022-08-01)

Evaluation of Bax In situ hybridization and PCNA Immunohistochemical Expression in Adenoid Cystic Carcinoma
Por: Lehadh Muhammed Al-Azzawi, et al.
Publicado em: (2019-07-01)

Evaluation of Bax In situ hybridization and PCNA Immunohistochemical Expression in Adenoid Cystic Carcinoma
Por: Lehadh Muhammed Al-Azzawi, et al.
Publicado em: (2019-07-01)

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
Por: Kottaridis, P, et al.
Publicado em: (2000)

The Evolving Treatment Landscape of AML
Por: Sabine Blum, et al.
Publicado em: (2022-03-01)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
Por: Peniket, A, et al.
Publicado em: (2005)

Evolving racial/ethnic disparities in AML survival in the novel therapy era
Por: Xin Wang, et al.
Publicado em: (2025-02-01)

Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression
Por: Xihan Liu, et al.
Publicado em: (2024-04-01)

Expression of BAX and Bcl-2 gene in prostate carcinoma and its correlation with gleason score
Por: Aiswarya Unnithan, et al.
Publicado em: (2023-01-01)

An optimized protocol for expression and purification of monomeric full-length BAX protein for functional interrogations
Por: Yiyang Chen, et al.
Publicado em: (2023-12-01)

Mechanisms of response and resistance to AML therapies
Por: Stoilova, B, et al.
Publicado em: (2020)

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?
Por: Hester F Lingsma, et al.
Publicado em: (2024-07-01)

Venetoclax for AML: changing the treatment paradigm
Por: Daniel A. Pollyea, et al.
Publicado em: (2019-12-01)

Electro-acupuncture modulated miR-214 expression to prevent chondrocyte apoptosis and reduce pain by targeting BAX and TRPV4 in osteoarthritis rats
Por: Jia He, et al.
Publicado em: (2024-05-01)

PB1918: HIGH BAX/BCL-2 RATIO IS ASSOCIATED WITH GOOD PROGNOSIS AND BETTER SURVIVAL IN PATIENTS WITH B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Por: Nesrine Helaly
Publicado em: (2023-08-01)

High-Resolution Pictures of AML Hierarchies
Por: Melania Tesio
Publicado em: (2019-06-01)

Expression profiling of snoRNAs in normal hematopoiesis and AML
Por: Wayne A. Warner, et al.
Publicado em: (2018-01-01)

Expression of Apoptotic Proteins Bax and Bcl-2 in Blood Cells of Type 2 Diabetic Patients
Por: Ebru Gokalp-Ozkorkmaz, et al.
Publicado em: (2018-12-01)

Modeling early treatment response in AML from cell-free tumor DNA
Por: Dantong Wang, et al.
Publicado em: (2023-12-01)

PB1821: THE INFLUENCE OF BCL2, BAX, BAX/BCL2 RATIO AND MDR1 GENE EXPRESSION ON PROGNOSIS OF ADULT DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE
Por: Zlatko Pravdic, et al.
Publicado em: (2023-08-01)

Protective Effects of Nucleobinding-2 After Cerebral Ischemia Via Modulating Bcl-2/Bax Ratio and Reducing Glial Fibrillary Acid Protein Expression
Por: Soheila Erfani, et al.
Publicado em: (2019-09-01)

Gene expression profiling in MDS and AML: potential and future avenues.
Por: Theilgaard-Mönch, K, et al.
Publicado em: (2011)

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively
Por: Reinaldo Dal Bello, et al.
Publicado em: (2023-01-01)

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
Por: Wheatley, K, et al.
Publicado em: (1995)